<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04583709</url>
  </required_header>
  <id_info>
    <org_study_id>2020-0465</org_study_id>
    <nct_id>NCT04583709</nct_id>
  </id_info>
  <brief_title>ECG Belt to Assess Electrical Synchronization</brief_title>
  <official_title>ECG Belt to Assess Electrical Synchronization in Patients With Left Bundle Branch Pacing and His-Purkinje Conduction System Optimized Cardiac Resynchronization Therapy (ECG Belt)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pugazhendhi Vijayaraman</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Geisinger Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to assess the utility of ECG Belt to understand the conduction&#xD;
      and ECG characteristics of Left Bundle Branch Pacing (LBBAP) and His-Optimized Cardiac&#xD;
      Resynchronization Therapy (HOT-CRT) and compare with preexisting data in traditional Cardiac&#xD;
      Resynchronization Therapy (CRT) and Right Ventricular Pacing (RVP).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of the study is to assess the utility of ECG Belt to understand the conduction&#xD;
      and ECG characteristics of LBBP and HOT-CRT and compare with preexisting data in traditional&#xD;
      CRT and RVP.&#xD;
&#xD;
      Specific Objective:&#xD;
&#xD;
        -  To demonstrate and establish electrical resynchronization using ECG Belt Research System&#xD;
           in Left Bundle Branch Pacing (LBBP) and HOT-CRT.&#xD;
&#xD;
        -  To assess ECG Belt derived native conduction parameters and compare them to LBBP and&#xD;
           HOT-CRT.&#xD;
&#xD;
        -  To compare with historic ECG belt parameters obtained for right ventricular pacing/&#xD;
           Biventricular pacing in prior studies.&#xD;
&#xD;
      The ECG Belt study is a prospective, single-center, investigational, pre-market research&#xD;
      study. The study team will identify all patients who satisfy the inclusion and exclusion&#xD;
      criteria. The study team will evaluate the ECG Belt Research System to assess the electrical&#xD;
      characteristics of conduction system pacing in patients with preexisting LBBP or HOT-CRT.&#xD;
&#xD;
      Eligible patients would have successfully undergone LBBP using Medtronic 3830 lead. LBBP will&#xD;
      be confirmed at implant using left bundle potentials recorded from the lead, ECG morphology&#xD;
      during unipolar and bipolar pacing, peak LV activation time and lead depth in the LV septum&#xD;
      by contrast at implant and 2D echo post-implant.&#xD;
&#xD;
      ECG belt would be used to record ECG during baseline rhythm, LBBP in unipolar and bipolar&#xD;
      configurations and / or during HOT-CRT using His-Bundle Pacing (HBP) or LBBP. These ECG belt&#xD;
      characteristics would then be compared with baseline and existing data on Right Ventricular&#xD;
      RV pacing and traditional Biventricular pacing.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2020</start_date>
  <completion_date type="Anticipated">February 28, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>• ECG Belt analysis of Standard Deviation of Activation Times (SDAT) of LBBP compared to native conduction</measure>
    <time_frame>Visit 1 Baseline-50 minutes</time_frame>
    <description>Change in SDAT following LBBP measured in ms.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>• ECG belt analysis of Left Ventricular activations times (LVAT) of LBBP compared to baseline</measure>
    <time_frame>Visit 1 Baseline-50 minutes</time_frame>
    <description>Change in LV activation times measured in ms.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>• ECG belt analysis of SDAT and LVAT of HOT-CRT compared to baseline</measure>
    <time_frame>Visit 1 Baseline-50 minutes</time_frame>
    <description>Change in SDAT and LVAT measured in ms</description>
  </primary_outcome>
  <primary_outcome>
    <measure>• ECG belt analysis of QRS duration at baseline compared to various LBBP options</measure>
    <time_frame>Visit 1 Baseline-50 minutes</time_frame>
    <description>Change in QRS duration measured in ms.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Bradycardia</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>ECG Belt</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ECG belt will be used to record ECG during baseline rhythm, LBBP in unipolar and bipolar configurations and / or during HOT-CRT using HBP or LBBP. These ECG belt characteristics would then be compared with baseline and existing data on RV pacing and traditional Biventricular pacing.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ECG Belt</intervention_name>
    <description>ECG Belt Research System Procedure LBBP Native conduction RV pacing if available Bipolar LBBP Unipolar LBBP - nonselective and selective (different outputs) Fusion pacing with native conduction at different Atrioventricular (AV) delays&#xD;
HOT-CRT Native conduction HBP / LBBP HOT-CRT AV delay optimization. Medtronic Device (pacemaker/ICD) based Holter recording during the ECG belt recording</description>
    <arm_group_label>ECG Belt</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients &gt; 18 years of age&#xD;
&#xD;
          2. Patient has a previously implanted LBBP lead for bradycardia indication or heart&#xD;
             failure indication with one of the following at Geisinger within the last 5 years:&#xD;
&#xD;
               -  LBBP&#xD;
&#xD;
               -  LBBP+LV lead&#xD;
&#xD;
               -  HBP+LV&#xD;
&#xD;
          3. Patient is willing to comply with all study procedures and be available for the&#xD;
             duration of the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Inability to provide informed consent&#xD;
&#xD;
          2. Pregnant&#xD;
&#xD;
          3. Enrolled in a concurrent study that may confound the results of this study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pugazhendi Vijayaraman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Geisinger Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pugazhendhi Vijayaraman, MD</last_name>
    <phone>570-808-6020</phone>
    <email>pvijayaraman1@geisinger.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Paul McDonough</last_name>
    <phone>570-808-3619</phone>
    <email>pjmcdonough@geisinger.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Geisinger Wyoming Valley</name>
      <address>
        <city>Wilkes-Barre</city>
        <state>Pennsylvania</state>
        <zip>18711</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vijayaraman Pugazhendi, MD</last_name>
      <phone>570-808-6020</phone>
      <email>pvijayaraman1@geisinger.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>September 29, 2020</study_first_submitted>
  <study_first_submitted_qc>October 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 12, 2020</study_first_posted>
  <last_update_submitted>January 19, 2021</last_update_submitted>
  <last_update_submitted_qc>January 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Geisinger Clinic</investigator_affiliation>
    <investigator_full_name>Pugazhendhi Vijayaraman</investigator_full_name>
    <investigator_title>Sponsor-Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bradycardia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

